Urine PD-L1 as a non-invasive biomarker for immune checkpoint inhibitor (ICI) therapy in bladder cancer.
- DOI
- 10.1016/j.abst.2025.05.001
- Published
- 2025
- Container
- Advances in biomarker sciences and technology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.abst.2025.05.001,
title = {Urine PD-L1 as a non-invasive biomarker for immune checkpoint inhibitor (ICI) therapy in bladder cancer.},
author = {Ge Q and Wang P and Wang SJ and Sood A and Meng L and Lee C and Parwani AV and Li J and Liu X},
year = {2025},
journal = {Advances in biomarker sciences and technology},
doi = {10.1016/j.abst.2025.05.001},
url = {https://doi.org/10.1016/j.abst.2025.05.001}
}RIS
TY - JOUR TI - Urine PD-L1 as a non-invasive biomarker for immune checkpoint inhibitor (ICI) therapy in bladder cancer. AU - Ge Q AU - Wang P AU - Wang SJ AU - Sood A AU - Meng L AU - Lee C AU - Parwani AV AU - Li J AU - Liu X PY - 2025 JO - Advances in biomarker sciences and technology DO - 10.1016/j.abst.2025.05.001 UR - https://doi.org/10.1016/j.abst.2025.05.001 ER -
APA
Q, G., P, W., SJ, W., A, S., L, M., C, L., AV, P., J, L., & X, L. (2025). Urine PD-L1 as a non-invasive biomarker for immune checkpoint inhibitor (ICI) therapy in bladder cancer.. Advances in biomarker sciences and technology. https://doi.org/10.1016/j.abst.2025.05.001
Source records
- pubmed · retrieved 2026-09-27T10:13:40.400Z